Abbott announced that the U.S. Food and Drug Administration (FDA) has
approved the company’s FreeStyle Libre Pro system, a revolutionary
continuous glucose monitoring (CGM) system for healthcare professionals
to use with their patients with diabetes.
FreeStyle
Libre Pro system is designed to empower healthcare professionals to
provide better diabetes management for diabetes patients. The system
provides healthcare professionals with a visual snapshot of glucose
data, known as the Ambulatory Glucose Profile (AGP), giving a more
simplified and clear overview of not only glucose levels, but also
patterns and trends within those levels. This valuable information helps
healthcare professionals make better, customized treatment decisions
for their patients – and for a significantly lower cost than other
professional CGM products availablei.
On nearly a daily basis, Eugene E. Wright, Jr., M.D. of Duke Southern Regional Area Health Education Center in Fayetteville, N.C., finds it challenging to effectively treat his patients with diabetes when it comes to decisions around insulin, nutrition and medication. “My patients are often out of range, due to inconsistent self-monitoring and insufficient data from traditional glucose meters that are unable to provide a full view of their glucose levels.”
A press release is availble from Abbott website.
On nearly a daily basis, Eugene E. Wright, Jr., M.D. of Duke Southern Regional Area Health Education Center in Fayetteville, N.C., finds it challenging to effectively treat his patients with diabetes when it comes to decisions around insulin, nutrition and medication. “My patients are often out of range, due to inconsistent self-monitoring and insufficient data from traditional glucose meters that are unable to provide a full view of their glucose levels.”
A press release is availble from Abbott website.
No comments:
Post a Comment